Stockreport

Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF - Phase 3 AZURE-1 enrollment complete- Phase 3 AZURE-4 screening complete- Topline AZURE-1 and AZURE-4 results expected in 2H 2026- AZURE-1 and AZURE-4 to form the basis [Read more]